Latest return on equity
Viridian Therapeutics Return on equity
Direct answer
Viridian Therapeutics's return on equity is -65.74%.
The verified market snapshot reports -65.74%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked September 25, 2026.
Get free Viridian Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Return on equity
- -65.74%
Explore related company data
View Viridian Therapeutics's market capitalizationView Viridian Therapeutics's price-to-book ratioView Viridian Therapeutics's 52-week price rangeView Viridian Therapeutics's revenue growthView Viridian Therapeutics's profit marginView Viridian Therapeutics's debt-to-equity ratioView all Viridian Therapeutics key metricsReturn to Viridian Therapeutics profile